Blogs about KG - Stockpickr! Your Source for Stock Ideas

Blogs about KG

Blogs	Description	Date Updated
Bristol-Myers: Losing the ImClone Battle, Winning the Erbitux War?	Is Bristol-Myers Squibb spewing sour grapes or singing of a successful strategy? The New York drug maker has lost out to Eli Lilly in the battle for ImClone, a battle it began in July by offering $60 a share for ImClone. (Associated Press) But instead of sounding disappointed at Lilly’s announcement that it would buy ImClone for $6.1 billion, or $70 a share, Bristol-Myers is acting as if getting Lilly to buy ImClone was its goal all along. In its statement today, Bristol-Myers calculat...	October 06, 2008
Alpharma: Above Buyout Premium on Exponential Volume (ALO, KG)	Alpharma inc. (NYSE: ALO) isn’t exactly your run of the mill “most active” stock, but it is this morning. King Pharmaceuticals (NYSE: KG) has offered to buy the drug company in a $1.4 Billion buyout valuing the company at $33.00 in cash per share. Shares are already up over that level at $34.20 after ten minutes of trading and we’ve already seen 6 million shares trade hands. Investors believe more of a premium may come down the road as has been the case elsewhere. ...	August 22, 2008
96th Edition of the Festival of Stocks	Welcome to the July 7th edition of the Festival of Stocks. The Festival of Stocks is a blog carnival dedicated to highlighting bloggers best posts on stock market related topics. Fat Pitch Financials is the actual birth place of this online weekly event, so it is always a special occassion when I get the chance to host this event. If you aren’t already familiar with my blog, Fat Pitch Financials, it is a value investing blog with a focus on wide moat companies selling at substantial discou...	July 07, 2008
Turkish ETF Here for Economic Reforms	The country of Turkey is getting a make-over and with the government implementing major economic reforms the exchange traded fund (ETF) can stand to benefit. Turkey has not gotten its membership into the European Union, but is hopeful as accelerated privatization is a major goal, reports KG Narandranath for Economic Times. Reforms are focused on areas like banking, agriculture, social security, energy and telecommunication. iShares MSCI Turkey Investable Market Index (TUR) launched in April an...	June 15, 2008
92nd Edition of the Festival of Stocks	Welcome to the June 9, 2008 edition of the Festival of Stocks. The Festival of Stocks is a blog carnival dedicated to highlighting bloggers best posts on stock market related topics. Fat Pitch Financials is the actual birth place of this online weekly event, so it is always a special occassion when I get the chance to host this event. If you aren’t already familiar with my blog, Fat Pitch Financials, it is a value investing blog with a focus on wide moat companies selling at substantial di...	June 09, 2008
Industry Ranks April 2008	Okay, here are my industry ranks for April 2008. Please remember that my model can be used in value mode (the green zone) or in momentum mode (the red zone). I usually just stick to the green zone, but this time I included a few red zone ideas. So, this time I added in technology companies, insurance, industrial and healthcare companies. Yeah, I know that’s a lot, and my results reflected that — usually I have just 20 or so companies from the screen, but this time it is 80+. Oh,...	April 10, 2008
Diagnosing Teva’s M&A Appetite	Does Teva Pharmaceutical have a multibillion deal on its shopping list? Citigroup analyst Andrew Swanson believes it should. Associated Press That is because the world’s largest maker of generic drugs laid out some bold growth goals last Thursday at its investor day. Teva said it expects to double its revenue to $20 billion by 2012 and, aside from a couple of complimentary acquisitions, it expects to do so primarily through organic growth. Swanson, though, believes that goal may be...	February 25, 2008
Weekend Reading - Buffett and Other Pros Reveal Lastest Holdings	The 13Fs came flying in this week. I hope you were able to keep up with all the news. If not, Value Investing News has got your back. Here are the top stories our members unearthed this week: Brush Up on Sherwin-Williams (SHW), But Still Too Soon to Buy Business Wire Canada Opening Reception: A Conversation with Warren Buffett (BRK-A) Good Things Come to Those with Patience (NOVN) Examples Of Bad Magic Formula Stocks (HLYS) (IAR) (KG) (USMO) Graham’s investing philosophy Pzena Investm...	February 15, 2008
Fast Money	Word On The StreetRecession concerns helped push the S&P 500 to 14-month lows on Wednesday. The Dow finished down 34 points and the NASDAQ closed down 23 points. Karen Finerman thinks the selloff is getting over done and she disclosed she bought Tesoro Corporation (TSO) Wednesday. She also disclosed she bought options for the Morgan Stanley Retail Index that expire Friday. Finerman th...	January 16, 2008
Ecolab Followup-Transforming from Soap to Services	About a month ago, I wrote a post on Ecolab (ECL) describing it as a model of consistency. As I quoted Dmitry Siulverstein who covers specialty chemical research at Longbow Research: I think the biggest appeal of Ecolab is predictability. The company gives you a very narrow guidance for earnings for the year, and a $0.02 range for earnings in the quarter. Quarter-in and quarter-out, they deliver results at the top end of their guidance. This predictability and sustainability of results, combine...	July 14, 2007

Enter search text here: